-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
3-Hydroxy-4-methoxycinnamic acid, predominantly trans
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/537-73-5.gif)
| Category | Influenza Virus |
| CAS | 537-73-5 |
| Description | 3-Hydroxy-4-methoxycinnamic acid display various pharmacological activities. 3-Hydroxy-4-methoxycinnamic acid anti-glycation agent, inhibits fructose- and glucose-mediated protein glycation. |
Product Information
| Synonyms | (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid |
| IUPAC Name | (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid |
| Molecular Weight | 194.18 |
| Molecular Formula | C10H10O4 |
| Canonical SMILES | COC1=C(C=C(C=C1)C=CC(=O)O)O |
| InChI | InChI=1S/C10H10O4/c1-14-9-4-2-7(6-8(9)11)3-5-10(12)13/h2-6,11H,1H3,(H,12,13)/b5-3+ |
| InChIKey | QURCVMIEKCOAJU-HWKANZROSA-N |
| Boiling Point | 410.2 °C at 760 mmHg |
| Melting Point | 228 - 233 °C |
| Flash Point | 167.6±19.4 °C |
| Purity | > 98 % |
| Density | 1.316 g/cm3 |
| Solubility | In Vitro: DMSO : 100 mg/mL(514.99 mM;Need ultrasonic) In Vivo: 1.Add each solvent one by one:10% DMSO >> 40%PEG300 >> 5%Tween-80 >> 45% saline Solubility: ≥ 2.08 mg/mL (10.71 mM); Clear solution 2.Add each solvent one by one:10% DMSO >> 90% (20%SBE-β-CD in saline) Solubility: ≥ 2.08 mg/mL (10.71 mM); Clear solution 3.Add each solvent one by one:10% DMSO >> 90%corn oil Solubility: ≥ 2.08 mg/mL (10.71 mM); Clear solution |
| Appearance | Powder |
| Application | Antioxidant |
| Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
| Complexity | 224 |
| Exact Mass | 194.05790880 |
| Index Of Refraction | 1.627 |
| PSA | 66.76000 |
| Target | Adrenergic Receptor; Influenza Virus |
| Vapor Pressure | 0.0±1.0 mmHg at 25°C |
| XLogP3-AA | 1.5 |
Description of First Aid Measures
Eye contact
Remove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids with fingers to ensure adequate flushing. Promptly call a physician.
Skin contactRinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.
InhalationImmediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.
IngestionWash out mouth with water; Do NOT induce vomiting; call a physician.